tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Swapnil Malekar, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).
Analyst Swapnil Malekar works with a stock forecast success ratio of 17.5% fulfilled within 13.25 days on average.
Swapnil Malekar’s has documented 27 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MRTX, Mirati Ther at 09-Aug-2023.
Analyst best performing recommendations are on NGM (NGM BIOPHARMACEUTICALS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1.55
$0.01 (0.65%)
9
1 months 28 days ago
4/6 (66.67%)
$0.02 (1.31%)
233
Buy
3.5
$1.96 (127.27%)
7
5 months 3 days ago
3/9 (33.33%)
$2.79 (392.96%)
262
Buy
3.5
$1.96 (127.27%)
7
5 months 3 days ago
0/2 (0%)
$2.79 (392.96%)
Buy
6
$4.46 (289.61%)
4
1 years 5 months 21 days ago
1/8 (12.5%)
$0.64 (11.94%)
3
Buy
4
$2.46 (159.74%)
36
1 years 6 months 8 days ago
4/6 (66.67%)
$0.59 (17.30%)
187
What Year was the first public recommendation made by Swapnil Malekar?
